South Korean biotech Sillajen was hit hard last week when its oncolytic virus therapy Pexa-Vec failed a phase 3 trial, but the company reckons it doesn’t spell the end of the programme. The oncolytic ...
The positive verdict of the US FDA's Oncologic Drugs Advisory Committee (ODAC) on Amgen's T-Vec (talimogene laherparepvec) is proving a boost to other companies developing oncolytic immunotherapies, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Disclaimer: these videos were produced in 2011, but we have had positive feedback in relation to them in 2016 so we hope you find them useful! The following links will take you videos of individual ...
Abstract: Vehicular Edge Computing (VEC) networks have emerged as an efficient paradigm to support a range of computation-intensive applications. However, potential eavesdropping attacks pose ...
The Virginia Employment Commission is resuming collection of its nearly $860 million in overpayments of unemployment insurance benefits to hundreds of thousands of people who lost their jobs during ...
Gov. Glenn Youngkin has appointed Carrie Roth to lead the Virginia Employment Commission, an embattled state agency that has struggled to process and pay almost 2 million claims for unemployment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results